Insiders · Profile

Cooper Laurence James Neil

President and CEO at Alaunos Therapeutics. Filing since 8 Nov 2017. CIK 0001641506

Company
Date
Role
Action
Shares
Amount
Of holding
4 Jan 2021
President and CEO
Sold, plan not stated
105,693
$286.43K
5.5%
30 Dec 2019
Chief Executive Officer
Sold, plan not stated
110,694
$540.19K
6.0%
8 Nov 2017
Chief Executive Officer
Bought
6,440
$30.14K
0.6%
3 decisions on file.